Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice - Wikidata - awgldk - TriplyDB

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

http://www.wikidata.org/entity/Q35370005

about

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment Combining radiotherapy and cancer immunotherapy: a paradigm shift Regulation of tumor metastasis by myeloid-derived suppressor cells New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo Anti-tumor immunity: myeloid leukocytes control the immune landscape Coordinated regulation of myeloid cells by tumours The emerging immunological role of post-translational modifications by reactive nitrogen species in cancer microenvironment Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment.Expansion of myeloid-derived suppressor cells with aging in the bone marrow of mice through a NF-κB-dependent mechanism.The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors Bacterial immunotherapy of gastrointestinal tumors.The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study.Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer models Myeloid-derived suppressor cells: paradoxical roles in infection and immunity.Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma.IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.Immune microenvironments in solid tumors: new targets for therapy.Therapeutic effect of intratumoral administration of DCs with conditional expression of combination of different cytokines.Differential macrophage programming in the tumor microenvironment.The nitric oxide radical scavenger carboxy-PTIO reduces the immunosuppressive activity of myeloid-derived suppressor cells and potentiates the antitumor activity of adoptive cytotoxic T lymphocyte immunotherapy.COX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells.Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties.The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion Molecular pathways: tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.Transcriptional regulation of myeloid-derived suppressor cells.Antigen spreading-induced CD8+T cells confer protection against the lethal challenge of wild-type malignant mesothelioma by eliminating myeloid-derived suppressor cells.Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages.Chemoresistance of human monocyte-derived dendritic cells is regulated by IL-17A.Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer.Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2.Simultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in mice.Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression

P2860

Q26744395-94BF3DB9-BE29-450E-85D9-8865C6FC2222 Q26799126-CD04FAD5-63A0-4F19-B99D-EB3B6E70084C Q27021428-89FF88EF-5F31-4111-8C80-44A2CA86271C Q27022125-9AB82D86-39E9-4EBD-B076-C3DFFADD3D6B Q28072045-808FD47A-91BB-4CBA-B110-3E08D8C9755D Q28084627-D2D2441D-F7DE-4A0C-B531-BCAA4652B23F Q28263221-B6D86D98-27F4-43DC-8B2F-A2D0819325C0 Q28390573-83C53542-EB32-4255-813A-D0993ED263CD Q28395157-8F776A2D-8480-45FF-B7F3-AF394CAC7F08 Q28396481-3D88AAA4-23D6-4DB6-A979-CFD8C44FB370 Q30415763-8DBC9E5D-47CE-4560-A1C6-21692B1E3204 Q33638965-6744C241-57BF-42EF-B5EB-5D45E2FA274C Q34228171-ACCD8EC6-FB4D-4B32-B62D-2A5251CA08BF Q34242204-497BF55D-04F8-4C49-BBDB-A0EBCC38B934 Q34315871-31E5AADB-42EC-4239-87D0-5B8E8C0B91BD Q34502899-55E2B46A-D91D-4C2D-A9DD-BBB9D0831FE5 Q34566554-0BB7CA48-4E36-4DFA-B3C3-0F8510F9BA33 Q34782683-B0B5CE38-F893-4CEC-98D2-286E4096803B Q35143001-C6E3E235-7381-4A6A-965E-F4847EF62E1C Q35169807-4175E5E8-9971-464D-A6E0-DB65EEA39FEB Q35506459-818EA52F-479D-4599-B8E9-FDCBA26A91C4 Q35578622-2CFA10E3-3DF0-4E03-8EA3-8BF4E90F433C Q35642044-DDC4FEAF-FE84-4BEC-AC46-2651BDA041F5 Q35741852-C2A82692-5C13-42DD-A37D-1D43181A7349 Q35803027-5066B60A-3BEA-44A1-8BEF-FA7AF006C6CD Q36060268-87D70583-77D3-42C5-8271-36CAA0E5518D Q36110362-A5F594C3-043A-48BD-9178-860E2EC16539 Q36188900-258FD666-13EA-4A3A-AA20-934A23B70485 Q36202213-97746F22-E5E0-43DA-B6E7-463C0C7BD960 Q36243616-B86191DA-C2B8-4A7B-9E6E-393EC4836037 Q36275124-D853C1E7-9CF5-4883-BC21-9C9486DF297A Q36293645-A5565301-33D9-4E27-993A-33936A287D89 Q36322351-9B815F61-57F1-4C3C-ACA2-954AB582D762 Q36544867-0BEC084B-BC45-47D2-AB26-3C4EF7605AC6 Q36562906-A19824D5-A29A-4F04-AECB-331FE7469FD7 Q36618689-ADF03DCB-E0DE-459C-95D3-2E24AC24BB6D Q36620552-05975E32-5399-4101-9D97-E6C5E86974F8 Q36767546-76C8B3C1-9E73-48A1-8468-25A00574582C Q36938866-26D7BC4A-1D62-4BE8-AED5-3156371F465D Q36983876-27358FBC-07D5-4705-8628-5400630204FB

P2860

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

http://www.wikidata.org/entity/Q35370005

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Tumor-infiltrating myeloid cel ...... e to cytotoxic T cells in mice

@ast

Tumor-infiltrating myeloid cel ...... e to cytotoxic T cells in mice

@en

type

label

Tumor-infiltrating myeloid cel ...... e to cytotoxic T cells in mice

@ast

Tumor-infiltrating myeloid cel ...... e to cytotoxic T cells in mice

@en

prefLabel

Tumor-infiltrating myeloid cel ...... e to cytotoxic T cells in mice

@ast

Tumor-infiltrating myeloid cel ...... e to cytotoxic T cells in mice

@en

P1433

Q35370005-BFFE21A3-855D-4367-AE52-226F0C8FB8BB

P1476

Q35370005-A46E50DB-D19A-4D58-913D-FBF62EF962DB

P2093

Q35370005-0029F4D9-A968-48DA-869A-82B6CF9D9034

Q35370005-25875417-3A57-4CDF-83F3-184ED5140C31

Q35370005-3DBB1A4E-DBCB-4A4C-A209-4694AB62C0C3

Q35370005-5256E90D-DC4C-4191-89B7-0B95A64F306A

Q35370005-940B2329-D080-4B58-8F75-749E921E21E6

Q35370005-CDC9352E-9E21-4134-8284-6455DEE74A5D

Q35370005-D001C19A-B77C-4AF7-9948-E8B28261C2AB

Q35370005-EB815436-95D0-4984-BC3E-501B84B8C160

Q35370005-FC99BE47-C5C2-469A-9388-2504D8347E6A

Q35370005-FDCF8443-62EC-40D7-B4A8-12FE70C88B69

P2860

Q35370005-0181E37B-91EA-4D7D-BC49-A7461947A51E

Q35370005-09F98B81-9DE5-4195-987A-99B3F12599F9

Q35370005-0F1B3649-5AC4-4BDC-A7F3-D3B62A294A93

Q35370005-13C34B76-C493-4EF9-88F0-FCBBAD6B7170

Q35370005-1D0D4CA1-9884-4268-B64D-628AEE5E422F

Q35370005-1FDC9665-5EBE-4489-80D3-8C8B34386F9B

Q35370005-24A2843A-4AEF-402E-83CA-3404DA698F21

Q35370005-271BC360-3D44-45CE-9828-7767DDC37A1F

Q35370005-32DA2518-C9AF-496C-A7A0-1018310E8834

Q35370005-34226862-5AA1-4FCD-823F-F487627774BC

P304

Q35370005-3EA57D41-5C76-45A1-BBDA-D7C47B4810B7

P31

Q35370005-D1379CE9-7EBC-46D0-841D-B70C258BB4D3

P356

Q35370005-8D8987D7-083E-4FB6-BD2F-22F160ED6CEA

P407

Q35370005-1C7D9F80-4511-4B8C-B9C7-FD7ED8E73A12

P433

Q35370005-67E09BB0-521A-4D2A-861F-8C6D890EF648

P478

Q35370005-B028C254-7B99-49C6-AA4C-51AAA0564C44

P577

Q35370005-43A8B973-F930-4B08-A335-CB30A2D9A751

P5875

Q35370005-53D1F4E9-0CFE-4C5B-9F8B-D98C15D8355A

P698

Q35370005-4ACA4239-8D36-4E8E-9B6B-8D00BC59111B

P921

Q35370005-604EBF8E-EEFA-4F3C-BD47-C5E92D281F89

P932

Q35370005-F3916942-CD4B-499F-B3B7-6AEA55AD4375

P356

P1433

Journal of Clinical Investigation

P1476

Tumor-infiltrating myeloid cel ...... e to cytotoxic T cells in mice

@en

P2093

Dmitry Gabrilovich

http://www.w3.org/2001/XMLSchema#string

Esteban Celis

http://www.w3.org/2001/XMLSchema#string

Je-In Youn

http://www.w3.org/2001/XMLSchema#string

Michael B Sporn

http://www.w3.org/2001/XMLSchema#string

Pingyan Cheng

http://www.w3.org/2001/XMLSchema#string

Rupal Ramakrishnan

http://www.w3.org/2001/XMLSchema#string

Simon Sherman

http://www.w3.org/2001/XMLSchema#string

Soner Altiok

http://www.w3.org/2001/XMLSchema#string

Tangying Lu

http://www.w3.org/2001/XMLSchema#string

Vladimir Pisarev

http://www.w3.org/2001/XMLSchema#string

P2860

T cell homeostatic proliferation elicits effective antitumor autoimmunity

Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress

Inflammation and cancer

Myeloid-derived suppressor cells as regulators of the immune system

Nitric oxide and the immune response

Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.

Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.

The immunobiology of low-dose total-body irradiation: more questions than answers.

Targeting inhibitory pathways in cancer immunotherapy.

Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression

P304

4015-4029

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI45862

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51632169

http://www.w3.org/2001/XMLSchema#string

P698

21911941

http://www.w3.org/2001/XMLSchema#string

P921

P932

3195459

http://www.w3.org/2001/XMLSchema#string